Literature DB >> 3622407

Long-term prognosis in childhood epilepsy: survival and seizure prognosis.

L O Brorson, L Wranne.   

Abstract

All children aged 0-19 years who had active epilepsy in a defined Swedish population were traced and given a clinical and psychometric investigation. Twelve years later, a follow-up study was carried out. Eleven of the 194 children had died, 8 of whom had had signs of neurodeficit, i.e., abnormal neurology and/or mental retardation. A long-standing remission of seizures occurred in 124 of the 194 children. Signs of neurodeficit, frequent seizures, and many types of seizures were negative prognostic factors. The presence of all these factors carried a bad prognosis, seizures persisting during 12 years in greater than 80%. For those who were mentally and neurologically normal and had low seizure frequency, prognosis was excellent, only 11% still having active epilepsy after 12 years. A study of the annual remission rate showed that each year approximately 13% of the children without neurodeficit had remission from epilepsy the next year. This rate appeared to be stable over the 12 years studied. Among those children with neurodeficit, the annual remission rate was high only during the first years after onset, later falling to 3% a year.

Entities:  

Mesh:

Year:  1987        PMID: 3622407     DOI: 10.1111/j.1528-1157.1987.tb03651.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  18 in total

1.  Mortality rates and causes of death in children with epilepsy prescribed antiepileptic drugs: a retrospective cohort study using the UK General Practice Research Database.

Authors:  Ruth Ackers; Frank M C Besag; Elaine Hughes; Waney Squier; Macey L Murray; Ian C K Wong
Journal:  Drug Saf       Date:  2011-05-01       Impact factor: 5.606

Review 2.  Management of intractable epilepsy.

Authors:  J H Livingston
Journal:  Arch Dis Child       Date:  1991-12       Impact factor: 3.791

3.  Predictors and course of medically intractable epilepsy in young children presenting before 36 months of age: a retrospective, population-based study.

Authors:  Elaine Wirrell; Lily Wong-Kisiel; Jay Mandrekar; Katherine Nickels
Journal:  Epilepsia       Date:  2012-06-27       Impact factor: 5.864

4.  Cognitive outcomes in children who present with a first unprovoked seizure.

Authors:  Yoshimi Sogawa; David Masur; Christine O'Dell; Solomon L Moshe; Shlomo Shinnar
Journal:  Epilepsia       Date:  2010-09-24       Impact factor: 5.864

5.  Early onset epilepsy is associated with increased mortality: a population-based study.

Authors:  Brian D Moseley; Elaine C Wirrell; Lily C Wong-Kisiel; Katherine Nickels
Journal:  Epilepsy Res       Date:  2013-04-11       Impact factor: 3.045

6.  Vigabatrin in the treatment of epilepsy in children.

Authors:  J H Livingston; D Beaumont; A Arzimanoglou; J Aicardi
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

Review 7.  Pharmacoresistance and the role of surgery in difficult to treat epilepsy.

Authors:  Samuel Wiebe; Nathalie Jette
Journal:  Nat Rev Neurol       Date:  2012-09-11       Impact factor: 42.937

Review 8.  Mortality in paediatric epilepsy.

Authors:  R E Appleton
Journal:  Arch Dis Child       Date:  2003-12       Impact factor: 3.791

9.  Epilepsy-related mortality is low in children: a 30-year population-based study in Olmsted County, MN.

Authors:  Katherine C Nickels; Brandon R Grossardt; Elaine C Wirrell
Journal:  Epilepsia       Date:  2012-09-18       Impact factor: 5.864

10.  What predicts enduring intractability in children who appear medically intractable in the first 2 years after diagnosis?

Authors:  Elaine C Wirrell; Lily C-L Wong-Kisiel; Jay Mandrekar; Katherine C Nickels
Journal:  Epilepsia       Date:  2013-04-03       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.